Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
familial partial lipodystrophy
MeSH D052496 - familial partial lipodystrophy
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D008060:
Lipodystrophy
2 Companies
1 Drug
$
Success rate
D000083083:
Laminopathies
1 Company
1 Drug
$
Success rate
D008052:
Inborn errors lipid metabolism
1 Company
1 Drug
$
Success rate
D052496:
Familial partial lipodystrophy
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Amryt Pharma
Metreleptin
Myalepta
2018-07-29
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
25
%
1/4
Phase 3
50
%
1/2
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amryt Pharma
Metreleptin
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use